Professional Experience
2008 – 2022: Scientific councellor, High Council on Public Health, Paris, France
2003 – 2008: Chargée de mission, Delegation for European and International Affairs, Ministry of Health, Paris, France
2003 – 2003: Expert in Surveillance and infection control, Asian Development Bank (ADB), China (July)
2002 – 2003: Consultant, PAHO/WHO (Pan American Health Organization/World Health Organization), Guyana and Haiti
1997 – 2002: Public Health Medical Officer, General Directorate for Health, Ministry of Health, Paris, France
Expertise and Research Interests
– Scientific counsel and coordination of working groups
– Public Health Policy, Strategy and Program Development and Dissemination, including IEC (Information Education and Communication) using New Information Technologies
– Surveillance, infection prevention and control, health education and promotion Applied research in Public Health related notably to infectious diseases and ethics in public health
– International Cooperation Program Development and Technical Assistance in low-income countries
– Inter-sectoral, cross-cultural, and interdisciplinary work development
Selected Publications
AndréJ.C., Frochot C., Manigat R., Allix F., Tomei F. (2013). Decreasing the gap between emerging nanotechnologies and citizen through ethical considerations and socially responsible research: the example of nano-drugs. Prevent Res 2013; 3 (2): 70-83.
Manigat R., Allix F., Frochot C., André J.C. (2011). Preventing societal health risks emerging in the development of nanomedicine – What should prevail? In: Risk Management / Book 1. InTech – Open Access Publisher. ISBN 979-953-307-232-5.
Couleaud, P.; Faure, M.; Verhille, M.; Manigat, R. & André, J.C. (2010). From public to occupational health: towards an inverse push-pull paradigm in nanotechnologies innovation, G. Ital. Med. Lav. Erg. 32:4, 400-402.
Manigat R., Wallet F. André J-C. From past to better public health programme planning for possible future global threats: case studies applied to infection control, Annali dell’instituto Superiore di Sanita, 2010, vol46 (3), 228-235.
Rey M. ; Aymard M. ; Manigat R. « Eradication of poliomyelitis in process. Hopes and difficulties of the last stage ». Editorial, Médecine et Maladies Infectieuses 2001 ; 31 : 375-7. The National Certification Commission for Poliomyelitis Eradication working group. « Update on the poliomyelitis eradication process ». Bulletin Epidémiologique Hebdomadaire 2000; 46-47: 201-21.1.
Desenclos J.C. ; Manigat R. « The European Union faces the threat of a pandemic: meeting at the DGV on influenza A (H5N1) of the ad hoc group on communicable diseases. Luxembourg, 14 January 1998. Eurosurveillance 1998 ; 3 : 25-6.
COST Action
European Sexual Medicine Network
COST Action CA18124
COST
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.